tiprankstipranks
Indivior PLC (DE:E7P)
NASDAQ:E7P
Germany Market
E7P
Indivior
RESEARCH TOOLSreports

Indivior (E7P) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

E7P Analyst Ratings

Strong Buy
3Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Indivior
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

E7P Stock 12 Month Forecast

Average Price Target

€46.09
▲(66.97% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Indivior in the last 3 months. The average price target is €46.09 with a high forecast of €50.82 and a low forecast of €41.35. The average price target represents a 66.97% change from the last price of €27.60.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"€10","51":"€51","20.25":"€20.3","30.5":"€30.5","40.75":"€40.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":50.82276874,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€50.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":46.085053009999996,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€46.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":41.34733728,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€41.35</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,20.25,30.5,40.75,51],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.4,31.97098221076923,33.54196442153846,35.11294663230769,36.68392884307692,38.25491105384615,39.82589326461539,41.39687547538462,42.96785768615385,44.53883989692308,46.10982210769231,47.68080431846154,49.25178652923077,{"y":50.82276874,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.4,31.606542539230766,32.81308507846153,34.01962761769231,35.226170156923075,36.43271269615384,37.63925523538461,38.84579777461538,40.05234031384615,41.25888285307692,42.46542539230769,43.67196793153846,44.87851047076923,{"y":46.085053009999996,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.4,31.242102867692306,32.084205735384614,32.92630860307692,33.76841147076923,34.610514338461535,35.452617206153846,36.29472007384615,37.13682294153846,37.978925809230766,38.82102867692308,39.66313154461538,40.505234412307686,{"y":41.34733728,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":11.1,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.5,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.18,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.4,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.4,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€50.82Average Price Target€46.09Lowest Price Target€41.35
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum Analyst forecast on DE:E7P
Chase Knickerbocker
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
06/04/26
Analysts Are Bullish on Top Healthcare Stocks: Elevance Health (ELV), Indivior (INDV)
Piper Sandler Analyst forecast on DE:E7P
David Amsellem
Piper Sandler
Piper Sandler
€46.52→€50.82
Buy
84.14%
Upside
Reiterated
05/22/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (NYSE: HIMS), AbCellera Biologics (NASDAQ: ABCL) and Indivior (NASDAQ: INDV)
H.C. Wainwright Analyst forecast on DE:E7P
Brandon Folkes
H.C. Wainwright
H.C. Wainwright
€41.35
Buy
49.81%
Upside
Reiterated
05/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (NASDAQ: REGN), Bausch + Lomb Corporation (NYSE: BLCO) and Indivior (NASDAQ: INDV)
Northland Securities Analyst forecast on DE:E7P
Carl Byrnes
Northland Securities
Northland Securities
€43.07
Buy
56.05%
Upside
Reiterated
02/27/26
Indivior (INDV) Gets a Buy from Northland Securities
Morgan Stanley Analyst forecast on DE:E7P
Thibault Boutherin
Morgan Stanley
Morgan Stanley
€24.12→€31.01
Buy
12.36%
Upside
Reiterated
12/03/25
Indivior price target raised to $36 from $28 at Morgan StanleyIndivior price target raised to $36 from $28 at Morgan Stanley
Jefferies Analyst forecast on DE:E7P
Dennis Ding
Jefferies
Jefferies
€17.23
Buy
-37.58%
Downside
Initiated
07/21/25
Positive Outlook for Indivior: Underestimated EPS Potential and Cost Reduction Opportunities
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum Analyst forecast on DE:E7P
Chase Knickerbocker
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
06/04/26
Analysts Are Bullish on Top Healthcare Stocks: Elevance Health (ELV), Indivior (INDV)
Piper Sandler Analyst forecast on DE:E7P
David Amsellem
Piper Sandler
Piper Sandler
€46.52→€50.82
Buy
84.14%
Upside
Reiterated
05/22/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (NYSE: HIMS), AbCellera Biologics (NASDAQ: ABCL) and Indivior (NASDAQ: INDV)
H.C. Wainwright Analyst forecast on DE:E7P
Brandon Folkes
H.C. Wainwright
H.C. Wainwright
€41.35
Buy
49.81%
Upside
Reiterated
05/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (NASDAQ: REGN), Bausch + Lomb Corporation (NYSE: BLCO) and Indivior (NASDAQ: INDV)
Northland Securities Analyst forecast on DE:E7P
Carl Byrnes
Northland Securities
Northland Securities
€43.07
Buy
56.05%
Upside
Reiterated
02/27/26
Indivior (INDV) Gets a Buy from Northland Securities
Morgan Stanley Analyst forecast on DE:E7P
Thibault Boutherin
Morgan Stanley
Morgan Stanley
€24.12→€31.01
Buy
12.36%
Upside
Reiterated
12/03/25
Indivior price target raised to $36 from $28 at Morgan StanleyIndivior price target raised to $36 from $28 at Morgan Stanley
Jefferies Analyst forecast on DE:E7P
Dennis Ding
Jefferies
Jefferies
€17.23
Buy
-37.58%
Downside
Initiated
07/21/25
Positive Outlook for Indivior: Underestimated EPS Potential and Cost Reduction Opportunities
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Indivior

3 Months
David AmsellemPiper Sandler
Success Rate
9/13 ratings generated profit
69%
Average Return
+21.27%
Copying David Amsellem's trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +21.27% per trade.
1 Year
David AmsellemPiper Sandler
Success Rate
12/13 ratings generated profit
92%
Average Return
+112.06%
Copying David Amsellem's trades and holding each position for 1 Year would result in 92.31% of your transactions generating a profit, with an average return of +112.06% per trade.
2 Years
Carl ByrnesNorthland Securities
Success Rate
12/12 ratings generated profit
100%
Average Return
+74.95%
Copying Carl Byrnes's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +74.95% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

E7P Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
2
3
2
2
1
Buy
11
8
6
3
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
11
8
5
4
In the current month, E7P has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. E7P average Analyst price target in the past 3 months is 46.09.
Each month's total comprises the sum of three months' worth of ratings.

E7P Financial Forecast

E7P Earnings Forecast

Next quarter’s earnings estimate for E7P is €0.76 with a range of €0.66 to €0.84. The previous quarter’s EPS was €0.83. E7P beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year E7P has Performed in-line its overall industry.
Next quarter’s earnings estimate for E7P is €0.76 with a range of €0.66 to €0.84. The previous quarter’s EPS was €0.83. E7P beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year E7P has Performed in-line its overall industry.

E7P Sales Forecast

Next quarter’s sales forecast for E7P is €266.03M with a range of €260.08M to €270.32M. The previous quarter’s sales results were €275.09M. E7P beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year E7P has Performed in-line its overall industry.
Next quarter’s sales forecast for E7P is €266.03M with a range of €260.08M to €270.32M. The previous quarter’s sales results were €275.09M. E7P beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year E7P has Performed in-line its overall industry.

E7P Stock Forecast FAQ

What is DE:E7P’s average 12-month price target, according to analysts?
Based on analyst ratings, Indivior PLC’s 12-month average price target is 46.09.
    What is DE:E7P’s upside potential, based on the analysts’ average price target?
    Indivior PLC has 66.97% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Indivior PLC a Buy, Sell or Hold?
          Indivior PLC has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Indivior PLC’s share price target?
            The average share price target for Indivior PLC is 46.09. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €50.82 ,and the lowest forecast is €41.35. The average share price target represents 66.97% Increase from the current price of €27.6.
              What do analysts say about Indivior PLC?
              Indivior PLC’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
                How can I buy shares of Indivior PLC?
                To buy shares of DE:E7P, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.